Stuart NS - Search Results

1

The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial.

O'Brien ME, Cullen MH, Woodroffe C, Kelly K, Burman C, Palmer K, Stuart NS, Blackledge GR, Sharpe J. O'Brien ME, et al. Among authors: stuart ns. Br J Cancer. 1989 Nov;60(5):759-63. doi: 10.1038/bjc.1989.354. Br J Cancer. 1989. PMID: 2679853 Free PMC article. Clinical Trial.

2

A new approach to the treatment of advanced high-grade non-Hodgkin's lymphoma--intensive two-phase chemotherapy.

Stuart NS, Blackledge GR, Child JA, Fletcher J, Perren TJ, O'Brien CJ, Jones EL, Ellis IO, Kavanagh JA, Kelly KA, et al. Stuart NS, et al. Cancer Chemother Pharmacol. 1988;22(2):141-6. doi: 10.1007/BF00257312. Cancer Chemother Pharmacol. 1988. PMID: 3409445

3

Long-term toxicity of chemotherapy for testicular cancer--the cost of cure.

Stuart NS, Woodroffe CM, Grundy R, Cullen MH. Stuart NS, et al. Br J Cancer. 1990 Mar;61(3):479-84. doi: 10.1038/bjc.1990.106. Br J Cancer. 1990. PMID: 2109631 Free PMC article.

4

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856).

Newlands ES, Blackledge GR, Slack JA, Rustin GJ, Smith DB, Stuart NS, Quarterman CP, Hoffman R, Stevens MF, Brampton MH, et al. Newlands ES, et al. Among authors: stuart ns. Br J Cancer. 1992 Feb;65(2):287-91. doi: 10.1038/bjc.1992.57. Br J Cancer. 1992. PMID: 1739631 Free PMC article. Clinical Trial.

5

A phase I study of meta-azidopyrimethamine ethanesulphonate (MZPES)--a new dihydrofolate reductase inhibitor.

Stuart NS, Crawford SM, Blackledge GR, Newlands ES, Slack J, Hoffman R, Stevens MF. Stuart NS, et al. Cancer Chemother Pharmacol. 1989;23(5):308-10. doi: 10.1007/BF00292409. Cancer Chemother Pharmacol. 1989. PMID: 2706736

6

A phase II study of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer.

Stuart NS, Cullen MH, Priestman TJ, Blackledge GR, Tyrrell CJ. Stuart NS, et al. Cancer Chemother Pharmacol. 1988;21(4):351-4. doi: 10.1007/BF00264204. Cancer Chemother Pharmacol. 1988. PMID: 3163529

7

ChlVPP/PABlOE and radiotherapy in advanced Hodgkin's disease. The Central Lymphoma Group.

Cullen MH, Stuart NS, Woodroffe C, Murphy A, Fletcher J, Blackledge GR, Child JA, Grieve RJ, Jones EL. Cullen MH, et al. Among authors: stuart ns. J Clin Oncol. 1994 Apr;12(4):779-87. doi: 10.1200/JCO.1994.12.4.779. J Clin Oncol. 1994. PMID: 7512132 Clinical Trial.

8

A randomised phase III cross-over study of tamoxifen versus megestrol acetate in advanced and recurrent breast cancer.

Stuart NS, Warwick J, Blackledge GR, Spooner D, Keen C, Taylor AR, Tyrell C, Webster DJ, Earl H. Stuart NS, et al. Eur J Cancer. 1996 Oct;32A(11):1888-92. doi: 10.1016/0959-8049(96)00191-8. Eur J Cancer. 1996. PMID: 8943670 Clinical Trial.

9

Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin's lymphoma. Central Lymphoma Group.

Bailey NP, Stuart NS, Bessell EM, Child JA, Norfolk D, Fletcher J, Grieve RJ, Simmons AV, Barnard DL, Jack A, Farish J, Dunn J, Woodroffe CM, Stack C, Cullen MH. Bailey NP, et al. Among authors: stuart ns. Ann Oncol. 1998 Jun;9(6):633-8. doi: 10.1023/a:1008276700860. Ann Oncol. 1998. PMID: 9681077 Free article. Clinical Trial.

10

Quality of life after treatment for testicular cancer--the patient's view.

Stuart NS, Grundy R, Woodroffe CM, Cullen MH. Stuart NS, et al. Eur J Cancer. 1990 Mar;26(3):291-4. doi: 10.1016/0277-5379(90)90224-h. Eur J Cancer. 1990. PMID: 2141485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page